KILITCH - Kilitch Drugs India

Kilitch Drugs India

KILITCH · Pharma > Pharmaceuticals & Drugs · MD: Mukund P Mehta · Listing date: Sept. 29, 2010 · Employees: 123 · Mumbai · http://www.kilitch.com

Stock Price vs Company Growth

2.3%

1.9%

4.4%

6.7%

11.5%

6.2%

30.7%

10y

24.4%

all

10.4%

🤔 How to analyze this graph?

Last Traded Price

₹ 320 2.3%

311

405

Company Overview

Sales

207 Cr

Growth: 17.0%

Profit after Tax

26 Cr

Growth: -5.5%

Small Cap

559 Cr

P/E: 20.2x

Industry P/E: 27.8x

Fundamentals

Sales (Cr)	₹ 207
Growth	17.0%
EBITDA	14.0%
P/S	2.7x
Dividend	0.0%
P/E	20.2x
Book Value	₹ 125
PEG Ratio	1.2x
ROE	12.4%
P/B	2.5x

Shareholding Pattern

Institutions

Dipak Kanayalal Shah

2.65 %

Iepf

1.5 %

Llp

0.05 %

Promoters

Kilitch Company (Pharma) Limited

42.6 %

Bhavin Mukund Mehta

12.87 %

Neeta Mukund Mehta

7.14 %

Mukund Mehta

5.72 %

Others

Increase Decrease No change

Company Profile Detailed

Kilitch Drugs is a pharmaceutical company, its services range from manufacturing to marketing a host of formulations in all dosage forms i.e. solid, liquid and parenteral forms. With nearly two decades of creating safe pharmaceutical solutions and the ultimate purpose of making the world a healthier place.Kilitch is one of the largest manufacturers of antibacterial parenteral formulations. It is also one of the largest producers of sterile liquid formulations in small volumes in India.

Investors (27)

dipak.ka...

dipak.sh...

mukund.p...

Followers (2)

paras5

varsha96